|
Market Closed -
Nasdaq
16:30:00 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 2.260 USD | +4.15% |
|
+0.44% | -65.88% |
| 08-14 | PAVmed Inc., Q2 2026 Earnings Call, Aug 14, 2026 | |
| 08-13 | PAVmed Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: PAVmed Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 216.3 | 44.98 | 33.17 | 6.946 | 6.103 | 15.8 | - |
| Change | - | -79.21% | -26.26% | -79.06% | -12.14% | 158.96% | - |
| Enterprise Value (EV) | 216.3 | 44.98 | 33.17 | 6.946 | 6.103 | 15.8 | 15.8 |
| Change | - | -79.21% | -26.26% | -79.06% | -12.14% | 158.96% | 0% |
| P/E | -3.78x | -0.62x | -0.45x | 1.25x | - | -0.62x | -1.14x |
| PBR | 3.45x | 3.91x | -1.24x | -2.82x | 0.18x | - | - |
| PEG | - | -0x | 0x | -0x | - | - | 0x |
| Capitalization / Revenue | 433x | 119x | 13.5x | 2.32x | 86x | 68x | 26.3x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 68x | 26.3x |
| EV / EBITDA | -0x | -0x | - | 0x | -0x | -1.6x | -1.7x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.55x | -0.61x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -292.5 | -351 | -274.8 | 15 | - | -3.62 | -1.98 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 0.5 | 0.377 | 2.452 | 2.995 | 0.071 | 0.2325 | 0.6 |
| EBITDA 1 | -50.12 | -85.25 | - | 40.55 | -0.217 | -9.9 | -9.3 |
| EBIT 1 | -54.39 | -90.93 | -68.8 | -44.49 | -21.81 | -28.63 | -25.86 |
| Net income 1 | -50.63 | -89.26 | -66.27 | 31.97 | -3.774 | -23.17 | -20.15 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 1,107.001 | 216.000 | 123.600 | 18.825 | 6.624 | 2.260 | 2.260 |
| Nbr of stocks (in thousands) | 195 | 208 | 268 | 369 | 921 | 6,993 | - |
| Announcement Date | 3/29/22 | 3/13/23 | 3/25/24 | 3/24/25 | 3/27/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 15.8M | |
| 34.53x | 5.85x | 22.47x | 0.28% | 253B | |
| 36.99x | 6.96x | 21.81x | 0.63% | 164B | |
| 51.68x | 12.65x | 27.12x | -.--% | 157B | |
| 17.34x | 3.44x | 11.18x | -.--% | 66.06B | |
| 49.46x | 12.26x | 27.02x | -.--% | 51.52B | |
| 20.71x | 2.48x | 12.52x | 2.44% | 52.64B | |
| 35.31x | 7.06x | 22.32x | -.--% | 52.2B | |
| 33.72x | 6.68x | 22.73x | 0.59% | 49.61B | |
| 79.42x | 7.56x | 22.95x | -.--% | 44.8B | |
| Average | 39.91x | 7.21x | 21.13x | 0.44% | 89.05B | |
| Weighted average by Cap. | 39.03x | 7.45x | 22.03x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PAVM Stock
- Valuation PAVmed Inc.
Select your edition
All financial news and data tailored to specific country editions
